Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Auburn, ME
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Butte, MT
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Edina, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Evanston, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Kettering, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Lyndhurst, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Vista, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
Clinical Research Facility
mi
from
Wichita, KS
Click here to add this to my saved trials
Opioid Use Disorder Clinical Trial
Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
Status: Enrolling
Updated: 4/21/2016
Royal Prince Alfred Hospital
mi
from
Camperdown Nsw,
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies
Status: Enrolling, Phase I
Updated: 3/14/2018
Florida Cancer Specialist and Research Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Status: Enrolling, Phase
Updated: 4/18/2018
McGill University
mi
from
Montreal,
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 414
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 103
mi
from
Huntsville, AL
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 235
mi
from
Nashville, TN
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 421
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 432
mi
from
Shreveport, LA
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
Ardelyx Investigative Site 423
mi
from
St. Louis, MO
Click here to add this to my saved trials
Spinal Stenosis Clinical Trial
The Coflex®COMMUNITY Study: An Observational Study of Coflex® Interlaminar Technology
Status: Enrolling, Phase
Updated: 12/31/1969
Laser Spine Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Spinal Stenosis Clinical Trial
The Coflex®COMMUNITY Study: An Observational Study of Coflex® Interlaminar Technology
Status: Enrolling, Phase
Updated: 12/31/1969
IGEA Brain and Spine
mi
from
Union, NJ
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Selinexor in Advanced Liposarcoma
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Duke Institute of Cancer
mi
from
Durham, NC
Click here to add this to my saved trials
Dedifferentiated Liposarcoma Clinical Trial
Selinexor in Advanced Liposarcoma
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Oregon Health & Science
mi
from
Portland, OR
Click here to add this to my saved trials
Acquired Hemophilia A Clinical Trial
Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A
Status: Enrolling, Phase
Updated: 3/22/2018
Blood Center of Southeast Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Chronic Heart Failure With Reduced Systolic Function Clinical Trial
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Heart Group of the Eastern Shore
mi
from
Fairhope, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Patients With Stage I-II HER2/Neu Positive Breast Cancer After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Nebraska Medicine-Village Pointe
mi
from
Omaha, NE
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis
Status: Enrolling, Phase I
Updated: 12/31/1969
The Emory ALS Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic Hospital - Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Cerebral Palsy Clinical Trial
Cerebral Palsy Hip Outcomes Project - International Multi-centre Study
Status: Enrolling, Phase
Updated: 12/31/1969
The Royal Children's Hospital
mi
from
Melbourne,
Click here to add this to my saved trials
Solid and Hematological Malignancies Clinical Trial
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling, Phase
Updated: 12/31/1969
UM St. Joseph Medical Center
mi
from
Towson, MD
Click here to add this to my saved trials
Non-ischemic Cardiomyopathy Clinical Trial
Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy
Status: Enrolling, Phase
Updated: 12/31/1969
University Health Network - Toronto General Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
Status: Enrolling, Phase III
Updated: 3/9/2018
Wayne State University - Karmanos Cacner Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
Status: Enrolling, Phase IV
Updated: 12/31/1969
San Diego VA Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Bedford, TX
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Greenwich, CT
Click here to add this to my saved trials
Lymphedema Clinical Trial
Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device (PCD)
Status: Enrolling, Phase
Updated: 12/31/1969
VA NY Harbor Healthcare System - Manhattan
mi
from
New York, NY
Click here to add this to my saved trials
Myasthenic Syndromes, Congenital Clinical Trial
Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes
Status: Enrolling, Phase III
Updated: 12/31/1969
Alberta Children's Hospital
mi
from
Calgary,
Click here to add this to my saved trials
Severe Postpartum Depression Clinical Trial
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
Status: Enrolling, Phase II
Updated: 5/26/2016
Cypress Medical Research
mi
from
Wichita, KS
Click here to add this to my saved trials
Her2 Positive Breast Cancer Clinical Trial
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Carbone Cancer Center / University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Valerius Research Center
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling, Phase IV
Updated: 4/1/2016
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling, Phase IV
Updated: 4/1/2016
Clinical Research Facility
mi
from
Homewood, AL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling, Phase IV
Updated: 4/1/2016
Clinical Research Facility
mi
from
Jeffersonville, IN
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling, Phase IV
Updated: 4/1/2016
Clinical Research Facility
mi
from
La Mesa, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling, Phase IV
Updated: 4/1/2016
Clinical Research Facility
mi
from
LawrenceVille, NJ
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling, Phase IV
Updated: 4/1/2016
Clinical Research Facility
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling, Phase IV
Updated: 4/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Urology Associates, PA
mi
from
Little Rock, AR
Click here to add this to my saved trials
Clinical Trial
Optimal Treatment for Recurrent Clostridium Difficile
Status: Enrolling, Phase IV
Updated: 12/31/1969
VA Caribbean Healthcare System, San Juan, PR
mi
from
San Juan,
Click here to add this to my saved trials
Solid Tumors Clinical Trial
A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Mary Crowely Cancer Research Centers- Medical City
mi
from
Dallas, TX
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Alabama at Birmingham School of Medicine
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Hôpital Jeanne de Flandre
mi
from
Lille,
Click here to add this to my saved trials
Sensorineural Hearing Loss Clinical Trial
Esteem New Subject Enrollment Post Approval Study
Status: Enrolling
Updated: 10/2/2017
Center for Neurosciences Ear and Hearing Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Chronic Pancreatitis Clinical Trial
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Columbia University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)
Status: Enrolling, Phase II
Updated: 9/11/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)
Status: Enrolling, Phase II
Updated: 9/11/2017
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)
Status: Enrolling, Phase II
Updated: 9/11/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)
Status: Enrolling, Phase II
Updated: 9/11/2017
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Status: Enrolling, Phase II
Updated: 6/28/2016
Merck Sharp & Dohme
mi
from
North Ryde,
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial to Evaluate Pemetrexed Clinical Responses in Relation to Tumor MTAP Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
MD Anderson Sugarland Regional Care Center
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Clinical Trial
Improving Function in Older Veterans With Hospital-Associated Deconditioning
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Regional VA Medical Center, Aurora, CO
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
A Randomized Trial of Recruitment Strategies for Research Participation
Status: Enrolling
Updated: 12/31/1969
Washington University: Siteman Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Status: Enrolling, Phase III
Updated: 5/22/2017
Odense University Hospital
mi
from
Odense C,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Indiana Blood and Marrow Institute Indiana Blood and Marrow Trans
mi
from
Beech Grove, IN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
McGovern Medical School at the University of Texas Health
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Vanderbilt University Medical Center, Clinical Trials Center Division Hematology/Oncology
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
University of Rochester Medical Center Univ of Rochester (7)
mi
from
Rochester, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Veterans Affairs Puget Sound Health Care System VAMC Seattle, WA Divison
mi
from
Seattle, WA
Click here to add this to my saved trials
Various Advanced Cancer Clinical Trial
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Erlanger Oncology & Hematology - Univ. Of Tn
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Various Advanced Cancer Clinical Trial
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Ft. Wayne Med Onco-Hema Inc
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Left Atrial Appendage Occlusion Registry (LAAO Registry)
Status: Enrolling
Updated: 6/27/2017
American College of Cardiology/National Cardiovascular Data Registry (NCDR)
mi
from
Washington DC,
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling, Phase IV
Updated: 12/31/1969
Health Partners Institute
mi
from
Bloomington, MN
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling, Phase IV
Updated: 12/31/1969
Northwell Health
mi
from
Manhasset, NY
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling, Phase IV
Updated: 12/31/1969
Cox Medical Center South
mi
from
Springfield, MO
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling, Phase II
Updated: 12/31/1969
Facility 1
mi
from
Boston, MA
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling, Phase II
Updated: 12/31/1969
Facility # 1
mi
from
Darlinghurst,
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling, Phase II
Updated: 12/31/1969
Facility 1
mi
from
San Diego, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Fluorescent Cholangiography vs White Light for Bile Ducts Identification
Status: Enrolling, Phase III
Updated: 1/31/2017
Hospital de clinicas jose de San Martin
mi
from
Buenos Aires,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery
Status: Enrolling, Phase
Updated: 4/6/2018
Royal Prince Alfred Hospital
mi
from
Sydney,
Click here to add this to my saved trials
Oncology Clinical Trial
Trial to Evaluate the Safety ofTalimogene Laherparepvec Injected Into Liver Tumors Alone and in Combination With Systemic Pembrolizumab
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Alpha1-antitrypsin Deficiency Clinical Trial
PH 3/4 GLASSIA SAFETY, IMMUNOGENICITY, AND BRONCHOALVEOLAR LAVAGE STUDY
Status: Enrolling, Phase III
Updated: 12/31/1969
LHSC - Victoria Hospital
mi
from
London,
Click here to add this to my saved trials
NASOPHARYNGEAL CARCINOMA Clinical Trial
A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California Davis Health
mi
from
Sacramento, CA
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
Arkansas Cardiology Clinic
mi
from
Little Rock, AR
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
New Life Medical Research Center
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
University of Pennsylvania, Parkinson's Disease and Movement Disorders Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
Bateman Home Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
Premeir Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
USF Parkinson's & Movement Disorders Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
Medical College of Ohio, Department of Neurology
mi
from
Toledo, OH
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
Georgetown University
mi
from
Washington DC,
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling, Phase III
Updated: 7/27/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling, Phase III
Updated: 7/27/2016
MSD Finland Oy
mi
from
Espoo,
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling, Phase III
Updated: 7/27/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling, Phase III
Updated: 7/27/2016
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
Moderate to Severe Primary Dysmenorrhea Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Status: Enrolling, Phase III
Updated: 7/27/2016
Clinical Research Facility
mi
from
Middleton, WI
Click here to add this to my saved trials